1. Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J. Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service. Clinicoecon Outcomes Res 2017;9:163-172. PubMed abstract

  2. Belsey J. Predictive validation of modeled health technology assessment claims: lessons from NICE. J Med Econ 2015 Nov 7:1-6. PubMed abstract

  3. Van Sanden S, Pisini M, Duchesne I, Mehnert A, Belsey J. Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology. Curr Med Res Opin 2016; 32(1):147-54.  PubMed abstract

  4. Belsey JD. Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind,randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66. Curr Med Res Opin 2015;31(6):1093-4. PubMed abstract.

  5. Belsey J. Appropriate use of information in therapeutic decision-making: reflections on indirect comparisons.Curr Med Res Opin 2014;31(2):343-346. PubMed abstract.

  6. Belsey J, Savelieva I, Mugelli A, Camm AJ. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis. Eur J Prev Cardiol 2014;22(7):837-48.  PubMed abstract.

  7. Belsey J. Teaching by humiliation-why it should change. Virtual Mentor 2014;16(3):217-219. PubMed abstract.

  8. Belsey J. Meditations on bowel preps. Dig Dis Sci 2013;58(8):2133-234. PubMed abstract.

  9. Mathus-Vliegen E, Pellisé M, Heresbach D, Fischbach W, Dixon T, Belsey J, Parente F, Rio-Tinto R, Brown A, Toth E, Crosta C, Layer P, Epstein O, Boustiere C. Consensus guidelines for the use of bowel preparation prior to colonic diagnostic procedures: colonoscopy and small bowel video capsule endoscopy. Curr Med Res Opin 2013;29(8):931-945. PubMed abstract.

  10. Halphen M, Heresbach D, Gruss HJ, Belsey J. Validation of the Harefield Cleansing Scale: a tool for the evaluation of bowel cleansing quality in both research and clinical practice. Gastrointest Endosc 2013;78(1):121-131. PubMed abstract.

  11. Belsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M. Meta-analysis: efficacy of small bowel preparation for small bowel video capsule endoscopy. Curr Med Res Opin 2012;28(12):1883-1890. PubMed abstract.

  12. Woodman J, Allister J, Rafi I, de Lusignan S, Belsey J, Petersen I, Gilbert R; RCGP Multisite Safeguarding Audit. A simple approach to improve recording of concerns about child maltreatment in primary care records: developing a quality improvement intervention. Br J Gen Pract 2012;62(600):e478-486. PubMed abstract.

  13. Belsey J. Optimising adherence in hypertension: a comparison of outcomes and costs using single tablet regimens versus individual component regimens. J Med Econ 2012;15:897-905. PubMed abstract.

  14. Belsey J, Crosta C, Epstein O et al. Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther 2012;35(2):222-237. PubMed abstract.  

  15. de Lusignan S, Nitsch D, Belsey J et al. Disparities in testing for renal function in UK primary care: cross-sectional study. Fam Pract 2011;28:638-646. PubMed abstract.

  16. Belsey JD. Choice of angiotensin receptor blocker in moderate hypertension. A UK-based cost-benefit comparison of olmesartan- and candesartan-based regimens. J Med Econ 2011;14:553-561. PubMed abstract.

  17. Gallacher SJ, Dixon T. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate and denosumab) on bone quality: a systematic review. Calcif Tissue Int 2010;87:469-484. PubMed abstract.

  18. Stewart A, Aubrey P, Belsey J. Addressing the health technology assessment of biosimilar pharmaceuticals.Curr Med Res Opin 2010;26:2119-2126. PubMed abstract.

  19. Belsey JD, Geraint M, Dixon TA. Systematic review and meta-analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract 2010;64:944-955. PubMed abstract.

  20. de Lusignan S, Khunti K, Belsey J, et al. Organisation and delivery of care: A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diab Med 2010; 27:203-209. PubMed abstract.

  21. Belsey J, Greenfield S, Candy D et al. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010;31:939-949. PubMed abstract.

  22. Belsey J. Principles of pharmaceutical marketing. In: Eds Edwards LD et al. Principles and practice of pharmaceutical medicine 3nd ed. Wiley London 2010.

  23. Belsey JD, Pittard JB, Rao S et al. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care. Int J Clin Pract 2009;63:439-448. PubMed abstract.

  24. Candy D, Belsey J. Macrogol (polyethylene glycol) based laxatives in children with functional constipation and faecal impaction: A systematic review. Arch Dis Childhood 2009;94:156-160. PubMed abstract.

  25. Belsey J, Epstein O, Heresbach, D. Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther 2008;29:15-28. PubMed abstract.

  26. Belsey J. Acute phosphate nephropathy--comment on Sica et al. Am J Gastroenterol 2008;103:800.  PubMed abstract.

  27. Belsey J. Trend in left handed presidents may be due to chance. BMJ 2008;337:a915. PubMed abstract.

  28. Belsey JD. Switch strategies in the management of hypertension: A cost minimisation analysis of angiotensin receptor blocker based regimen. Curr Med Res Opin 2008;24:581-589. PubMed abstract.

  29. Belsey J, de Lusignan S, van Vlymen J et al. Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy. Curr Med Res Opin 2008;24:2703-2709. PubMed abstract.

  30. Belsey J, de Lusignan S, Chan T et al. Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data. Curr Med Res Opin 2008;24:2551-2560. PubMed abstract.

  31. Belsey J, Krishnarajah G. Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin sulphonylurea: a meta-analysis. Diabetes Obes Metab 2008;10 Suppl 1:1-7. PubMed abstract.

  32. Pearse RM, Belsey JD, Cole JN et al. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med 2008;36:1323-1329.PubMed abstract.

  33. Amiel SA, Dixon T, Mann R et al. Hypoglycaemia in type 2 diabetes. Diabetic Med 2008;25:245-254.PubMed abstract.

  34. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007;25:373-384. PubMed abstract.

  35. Gallacher SJ, Gallagher AP, McQuillian C et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int 2007;18:185-192. PubMed abstract.

  36. Belsey J. Principles of pharmaceutical marketing. In: Eds Edwards LD et al. Principles and practice of pharmaceutical medicine 2nd ed. Wiley London 2007.

  37. de Lusignan S, Hague N, Belsey J et al. The 'rule of halves' still applies to the management of cholesterol in cardiovascular disease: 2002-2005. Brit J Cardiol 2006;13:145-153.

  38. Belittlement and harassment of medical students: seems to achieve focus. BMJ 2006;333:920. PubMed abstract.

  39. Beringer T, Heyburn G, Finch M et al. Prevalence of vitamin D inadequacy in Belfast following fragility fracture.Curr Med Res Opin 2006;22:101-105. PubMed abstract.

  40. Bayly JR, Hollands RD, Riordan-Jones SE et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin2006;22:131-137. PubMed abstract.

  41. Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway.Curr Med Res Opin 2006;22:211-216. PubMed abstract.

  42. Dixon T, Mitchell P, Beringer T et al. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin2006;22:405-415. PubMed abstract.

  43. de Lusignan S, Belsey J, Hague N et al. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study. J Public Health (Oxf) 2006;28:361-369. PubMed abstract.

  44. Bellavance A, Belsey J. Triptan preference in acute migraine management: A retrospective review of patient records from a Canadian clinic population. Headache Care 2006;3:39-43.

  45. Gallacher SJ, McQuillian C, Harkness M et al. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin 2005;21:1355-1361. PubMed abstract.

  46. Moniz C, Dixon T, Dew T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London.Curr Med Res Opin 2005;21:1891-1894. PubMed abstract.

  47. De Lusignan S, Belsey J, Hague N et al. End-digit preference in blood pressure recordings of patients with ischaemic heart disease in primary care. J Hum Hypertens 2004;18:261-265. PubMed abstract.

  48. Belsey JD. Cost effectiveness of oral triptan therapy: A trans-national comparison based on a meta-analysis of randomised controlled trials. Curr Med Res Opin 2004;20:659-669. PubMed abstract.

  49. Belsey JD. Non-steroidal anti-inflammatory induced upper gastrointestinal event rates in patients awaiting joint replacement in the United Kingdom. An epidemiologically-based burden of disease model. Curr Med Res Opin 2003;19:306-312. PubMed abstract.

  50. Belsey J, Adelman JU. Meta-analysis methodology: The battle continues. Headache 2003;43:1119-1121.PubMed abstract.

  51. Belsey J, Adelman JU. Updated meta-analysis of oral triptan therapy for migraine: Number needed to treat (NNT) and relative cost to achieve 2-hour pain-free status. Headache 2003;43:565 (Abst S114).

  52. Adelman JU, Belsey J. Meta-analysis of oral triptan therapy for migraine: Number needed to treat and relative cost to achieve relief within 2 hours. J Managed Care Pharm 2003;9:45-52. PubMed abstract.

  53. Belsey J. Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care. J Med Econ 2002;5:39-50.

  54. Belsey JD. The clinical and financial impact of oral triptans – an updated meta-analysis. J Med Econ 2002;5:79-89.

  55. Belsey J. Effect of varying pooling methods and analytical techniques on the qualitative results of triptan meta-analyses. Headache 2002;42:408.

  56. Belsey J. Me-graine or my-graine: An etymological headache. Headache 2002;42:445 (Abst S83).

  57. Belsey J. Clinical efficacy and cost-effectiveness of oral triptans: An updated meta-analysis incorporating data for almotriptan. Cephalalgia 2001;21:407 (Abst P2-K5)

  58. Belsey J. Reconciling effectiveness and tolerability in oral triptan therapy: A quantitative approach to decision making in migraine management. J Clin Res 2001;4:105-125.

  59. Belsey JD. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. J Med Econ 2000;3:35-47.

  60. Phillips C, Belsey J, Shindler J. Flora pro.activ: A clinical and financial impact analysis. J Med Econ 2000;3:61-76.

  61. Belsey J. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. Cephalalgia 2000;20:412 (Abst 365).

  62.  Belsey JD. Clinical outcomes in osteoporosis: The fracture intervention trial in context. Medical Dialogue 1997;480.